Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlue Star Regulatory News (BLU)

Share Price Information for Blue Star (BLU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0325
Bid: 0.03
Ask: 0.035
Change: 0.0025 (8.33%)
Spread: 0.005 (16.667%)
Open: 0.03
High: 0.0325
Low: 0.03
Prev. Close: 0.0325
BLU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants and Director’s Dealing

9 Nov 2020 07:00

RNS Number : 5934E
Blue Star Capital plc
09 November 2020
 

9 November 2020

 

Blue Star Capital plc

 

("Blue Star" or the "Company")

 

Exercise of Warrants and Director's Dealing

 

 

Blue Star Capital plc (AIM: BLU), the investing company with a focus on esports, payments, technology and its applications within media and gaming, has been notified of the exercise of warrants over 95,000,000 new ordinary shares at a price of 0.1p per share and of a director's dealing as detailed below.

 

Exercise of Warrants

 

On 14 October 2019, the Company announced that had agreed to issue warrants to Jonathan Bixby, through his Company Toro Consulting Ltd and to certain directors conditional on the completion of the initial fundraising in connection with the Company's esports investment portfolio. The warrants granted included warrants over 300,000,000 new ordinary shares with an exercise date of 6 November 2020 and an exercise price of 0.1p per share.

 

The Company was notified on 6 November 2020 that shareholders including Anthony Fabrizi, a director of the Company, had exercised warrants over 95,000,000 new ordinary shares ("New Ordinary Shares"). The exercise of the warrants has raised £95,000 for the Company and the remainder of the warrants due to mature on 6 November 2020 have now expired.

 

Following the exercise and expiry of warrants detailed above, the Company has warrants outstanding over 1,299,333 new ordinary shares of which 707,666 warrants are exercisable at 0.175p on or before 8 June 2021 and 591,667 warrants are exercisable at 0.25p on or before 6 November 2021.

 

In connection with his exercise of warrants, Anthony Fabrizi notified the Company on 6 November 2020 that, on the same day, he sold 10,000,000 shares in the Company at an average price of 0.152p.

 

Director's Dealing

 

As a result of the exercise of warrants and the sale of shares detailed above, the following dealings by a director have occurred:

 

Name

Holding prior to transactions

Number of shares sold

Number of shares acquired subject to exercise of warrants

Holding following sale and Admission

Holding as a percentage of issued share capital following Admission

 

 

 

 

 

 

Anthony Fabrizi

 

62,000,000

10,000,000

25,000,000

77,000,000

1.86%

 

 

Application will shortly be made for the 95,000,000 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on or around 13 November 2020. The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares.

 

Total Voting Rights

 

In conformity with DTR 5.6.1, the Company notifies that as at the date of this announcement, it has a single class of shares in issue being Ordinary Shares and that following the issue of the New Ordinary Shares to be issued in connection with the conversion of his loan notes, the total number of Ordinary Shares in issue will be 4,144,249,518. There are no Ordinary Shares held in treasury. Each Ordinary Share entitles the holder to a single vote at general meetings of the Company.

 

The figure of 4,144,249,518 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The following disclosure in the table below, in accordance with the requirements of Article 19(1) of Regulation (EU) No. 596/2014, provides further detail on the sale of shares and exercise of warrants.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

For further information please contact:

 

Blue Star Capital plc

Tony Fabrizi

 

 

+44 (0) 777 178 2434

 

Cairn Financial Advisers LLP

Jo Turner / Liam Murray

 

 

 +44 (0) 20 7213 0880

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a.

Name

Anthony Fabrizi

 

2

Reason for notification

 

a.

Position/Status

Chief Executive Officer

 

b.

Initial notification/

Amendment

Initial

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a.

Name

Blue Star Capital PLC

 

b.

LEI

213800WAVVOPS85N2205

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares

 

 

ISIN: GB00B02SSZ25

 

 

 

b.

Nature of the transaction

Sale of shares at a price of 0.152 pence

Exercise of warrants at an exercise price of 0.1 pence

 

c.

Price(s) and volume(s)

 

 

 

 

 

 

Volume(s)

Exercise Price (p)

 

 

10,000,000

0.152

 

 

 

25,000,000

0.1

 

 

 

 

d.

Aggregated information

- Aggregated Volume

- Price

35,000,000

 

0.152 and 0.1 pence per share

 

e.

Date of the transaction

06/11/2020

 

 

f.

Place of the transaction

London Stock Exchange, AIM

 

 

         

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKCBQKBDKKDK
Date   Source Headline
26th Jun 202010:21 amRNSHolding(s) in Company
25th Jun 20207:00 amRNSGuild Esport Investment Update
24th Jun 20207:00 amRNSDynasty Esports Investment Update
23rd Jun 20207:00 amRNSLeaf Mobile Update
15th Jun 20209:12 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSPlacing and Issue of Equity
28th May 20207:00 amRNSSatoshiPay Update
4th May 20203:17 pmRNSSubscription, Director’s Dealing and Investment
17th Apr 20205:17 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSPlacing, Director's Dealing and Investment
31st Mar 202012:25 pmRNSResult of AGM
26th Mar 20204:49 pmRNSChange of Venue for AGM and other arrangements
5th Mar 20207:00 amRNSFinal Results
19th Feb 20209:42 amRNSExercise of Warrants
3rd Feb 202010:07 amRNSUpdate on Esports Investment
27th Jan 20207:00 amRNSChange of Adviser
14th Jan 20207:00 amRNSUpdate on Esports Investment
11th Dec 20198:58 amRNSHolding(s) in Company
27th Nov 20197:00 amRNSUpdate on SatoshiPay
19th Nov 20191:52 pmRNSHolding(s) in Company
15th Nov 20194:58 pmRNSHolding(s) in Company
6th Nov 201912:25 pmRNSResult of General Meeting and Directorate Changes
16th Oct 20193:31 pmRNSPosting of Circular and Notice of General Meeting
14th Oct 20197:00 amRNSPlacing and Investments in Esports Opportunities
1st Jul 20197:00 amRNSIssue of Equity
25th Jun 20197:00 amRNSHalf-year Report
30th Apr 20194:41 pmRNSSecond Price Monitoring Extn
30th Apr 20194:36 pmRNSPrice Monitoring Extension
29th Mar 20191:13 pmRNSResult of AGM
18th Mar 20199:27 amRNSHolding(s) in Company
7th Mar 20197:00 amRNSSatoshiPay Partnership with Börsenmedien AG
5th Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSSatoshiPay Fundraise
6th Feb 20197:00 amRNSSatoshiPay Fundraise and Conversion of Loan Notes
4th Feb 201910:15 amRNSHolding(s) in Company
31st Jan 20198:00 amRNSSatoshiPay partnership with Axel Springer SE
29th Jan 20198:01 amRNSHolding(s) in Company
24th Jan 20197:30 amRNSRestoration - Blue Star Capital Plc
24th Jan 20197:00 amRNSRestoration of Trading and General Update
20th Dec 20187:00 amRNSFurther Extension to Exclusivity Agreement
26th Oct 201811:00 amEQSHardman & Co Research: SatoshiPay: An emerging leader in digital nanopayments
23rd Oct 20187:00 amRNSExtension to Exclusivity Agreement
26th Jul 20187:30 amRNSSuspension - Blue Star Capital Plc
26th Jul 20187:00 amRNSSuspension and Potential Acquisition
11th Jul 20188:39 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSHalf-year Report
28th Jun 201810:12 amRNSHolding(s) in Company
19th Jun 20182:37 pmRNSHolding(s) in Company
7th Jun 20187:00 amRNSSthaler Update
22nd May 20187:00 amRNSSatoshiPay Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.